| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/04/1998 | EP0821670A1 N-aroylamino acid amides as endothelin inhibitors |
| 02/04/1998 | EP0821669A1 Hydroxamic and carboxylic acids as metalloprotease inhibitors |
| 02/04/1998 | EP0821665A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase |
| 02/04/1998 | EP0821572A1 Magnesium taurate as a therapeutic agent |
| 02/04/1998 | EP0675721B1 Pharmaceutical compositions comprising contignasterol compounds |
| 02/04/1998 | EP0667856B1 Novel vitamin d analogues |
| 02/04/1998 | CN1172486A Proline derivatives useful as inhibitors of human leukocyte elastase |
| 02/04/1998 | CN1172483A Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
| 02/04/1998 | CN1172475A Antiarrhythmic (S) -enantiomers of methanesulfonamides |
| 02/04/1998 | CN1172104A Substituted lndanylidineacetylguanidines, process for their preparation, their use as medicaments of diagnostic and medicaments containing them |
| 02/04/1998 | CN1171947A Drug preparation for curing viral and many kinds of myocarditis, low fever and hypokalemia |
| 02/03/1998 | US5714508 Inhibitors of angiotensin ii |
| 02/03/1998 | US5714502 Atypical neuraleptics having no cataleptic side effects; schizophrenia, antidepressants; analgesics; hypotensive agents; extrapyramidal disorders |
| 02/03/1998 | US5714500 2-phenyl- and 2-thienyl-(2)-piperidine derivatives having neuroprotective properties |
| 02/03/1998 | US5714496 Quinuclidine derivatives as squalene synthase inhibitors |
| 02/03/1998 | US5714494 For treating atherosclerosis |
| 02/03/1998 | US5714487 2,7-substituted octahydro-pyrrolo 1,2-a!pyrazine derivatives |
| 02/03/1998 | US5714486 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 02/03/1998 | US5714484 α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 02/03/1998 | US5714381 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 02/03/1998 | US5714353 Safe vectors for gene therapy |
| 02/03/1998 | CA2128093C 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxoquinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| 02/03/1998 | CA2081564C Synergistic therapeutic compositions and methods |
| 02/03/1998 | CA2044748C Pyrazolopyrimidinone antianginal agents |
| 02/03/1998 | CA1339660C Derivatives of cyclohexane |
| 01/29/1998 | WO1998003665A1 Human kallikrein |
| 01/29/1998 | WO1998003634A1 Methods for identifying vasoprotective agents |
| 01/29/1998 | WO1998003573A1 Angiogenic inhibitory compounds |
| 01/29/1998 | WO1998003539A1 G-protein coupled receptor hnfds78 |
| 01/29/1998 | WO1998003516A1 Phosphinate based inhibitors of matrix metalloproteases |
| 01/29/1998 | WO1998003507A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 01/29/1998 | WO1998003496A1 Furan nitrone compounds |
| 01/29/1998 | WO1998003494A1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
| 01/29/1998 | WO1998003493A1 Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands |
| 01/29/1998 | WO1998003492A1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 01/29/1998 | WO1998003469A1 Benzoylpropionic acid ester derivatives |
| 01/29/1998 | WO1997036609A3 Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest |
| 01/29/1998 | CA2261031A1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 01/29/1998 | CA2261013A1 Human kallikrein |
| 01/29/1998 | CA2260990A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 01/29/1998 | CA2260983A1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
| 01/29/1998 | CA2260982A1 Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands |
| 01/29/1998 | CA2260825A1 Furan nitrone compounds |
| 01/29/1998 | CA2258074A1 Benzoylpropionic acid ester derivatives |
| 01/28/1998 | EP0821061A2 Calcitonin gene-related peptide receptor component factor (houdc44) |
| 01/28/1998 | EP0820991A2 Cycloalkyl derivatives as bone resorption inhibitors and vitronectin receptor antagonists |
| 01/28/1998 | EP0820988A2 Imino derivatives as bone resorption inhibitors and vitronectin receptor antagonists |
| 01/28/1998 | EP0820455A1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES |
| 01/28/1998 | EP0820441A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS |
| 01/28/1998 | EP0820434A1 Phenoxyethylamine derivatives having high affinity for the 5-ht 1a receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives |
| 01/28/1998 | EP0820428A1 Terminal carboxy or tetrazole groups containing dialkyl ethers |
| 01/28/1998 | EP0820302A1 Combination compositions containing benazepril or benazeprilat and valsartan |
| 01/28/1998 | EP0609336B1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered |
| 01/28/1998 | EP0606318B1 Vanadium compositions |
| 01/28/1998 | EP0422217B1 Human recombinant placental ribonuclease inhibitor and method of production |
| 01/28/1998 | CN1171793A Gas phase polymerization process |
| 01/28/1998 | CN1171739A Use of nebivolol as anti-atherogenic |
| 01/28/1998 | CN1171397A Crystal of N-£(quinolin-2-yl) phenyl| sulfonamides and process for producing same |
| 01/28/1998 | CN1171394A New urea derivatives, their preparation and their therapeutic and prophylactic use |
| 01/28/1998 | CN1171248A Chinese medicine capsule for treating apoplexy |
| 01/28/1998 | CN1037201C 多元溶剂清洗系统 Multiple solvent cleaning system |
| 01/28/1998 | CN1037179C 1, 4 -benzoxazino derivatives |
| 01/28/1998 | CN1037176C Benzenealkanoic acids for cardiovascular diseases |
| 01/27/1998 | US5712380 Angiogenesis inhibitor |
| 01/27/1998 | US5712312 Melatoninergic receptor ligands, treatment of sleep disorders |
| 01/27/1998 | US5712299 (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl methylamine derivatives |
| 01/27/1998 | US5712296 Substituted pyridines and 2-oxo-1,2-dihydropyridines |
| 01/27/1998 | US5712291 Methods and compositions for inhibition of angiogenesis |
| 01/27/1998 | US5712284 Azalicyclooctane derivatives as anti-arrhythmic agents |
| 01/27/1998 | US5712279 Inhibitors of microsomal triglyceride transfer protein and method |
| 01/27/1998 | US5712276 Treating nervous system disorders |
| 01/27/1998 | US5712249 Use of insulin-like growth factors I and II for inhibition of inflammatory response |
| 01/27/1998 | US5712155 DNA encoding tumor necrosis factor-α and -β receptors |
| 01/27/1998 | US5712111 DNA encoding bradykinin B1 receptor |
| 01/27/1998 | US5711983 Dinoflagellate biomass, methods for its production, and compositions containing the same |
| 01/27/1998 | CA2037009C 15-dehydroxy-16-oxoprostaglandins |
| 01/27/1998 | CA1339645C Pyridinium derivatives, their production and use |
| 01/24/1998 | CA2211148A1 Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 01/22/1998 | WO1998002436A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase |
| 01/22/1998 | WO1998002413A1 Substituted n-arylmethylamino derivatives of cyclobutene-3,4-diones |
| 01/22/1998 | WO1998002190A2 Cationic amphiphile/dna complexes |
| 01/22/1998 | WO1998002183A1 Medicinal compositions |
| 01/22/1998 | WO1998002159A1 Novel treatment of leptine resistance |
| 01/22/1998 | WO1996020698A3 Surface-modified nanoparticles and method of making and using same |
| 01/22/1998 | DE19730990A1 New (amidino-phenyl)-(benzo:dioxolo-methyl)oxo-pyrrolo:pyrrole compounds |
| 01/22/1998 | CA2547967A1 System for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment |
| 01/22/1998 | CA2261072A1 Substituted n-arylmethylamino derivatives of cyclobutene-3,4-diones |
| 01/22/1998 | CA2260216A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase |
| 01/22/1998 | CA2260044A1 Novel treatment of leptine resistance |
| 01/22/1998 | CA2260034A1 Cationic amphiphile/dna complexes |
| 01/21/1998 | EP0819687A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/21/1998 | EP0819686A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/21/1998 | EP0819681A2 N-(4-Aryl-thiazol-2-yl)-sulfonamides and their use |
| 01/21/1998 | EP0819125A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/21/1998 | EP0819001A1 Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders |
| 01/21/1998 | EP0625977B1 Piperazine derivatives as 5-ht1a antagonists |
| 01/21/1998 | EP0594636B1 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 01/21/1998 | CN1171117A Use of MHC-II binding and/or MHC-II minicking molecules for prevention and/or treatment of inflammatory diseases |
| 01/21/1998 | CN1171104A Aminotetrazole derivatives useful as nitric oxide synthase inhibotors |
| 01/21/1998 | CN1171045A Hemorrhoidal compositions and method of use |